The Total Addressable Market (TAM) for Medical Tubing was valued at USD 12.16 billion in 2022. It is projected to reach USD 19.52 billion by 2031, growing at a CAGR of 5.40% during the forecast period (2023–2031). Medical tubing, made from a polymer through an extrusion process, has many applications, including peristaltic pumps, feeding tubes, and drug delivery systems. Because of their exceptional thermal, mechanical, and chemical properties, the tubes are used in various minimally invasive applications, such as stent delivery systems, cardiovascular catheters, and urological retrieval devices. Anesthesia machines, ventilators, intravenous lines, and biopharmaceutical lab apparatus all use medical tubing. Certifications and standard procedures are enforced during production and used to guarantee the highest level of product safety. The expansion of the medical tubing market can be directly attributed to the rising prevalence of various medical conditions and disorders, including cardiovascular, gastrointestinal, urological, and other types.
Get more information on this report Download Sample Report
Paradigm Shift towards Minimal Invasive Medical Procedure
The minimally invasive medical procedure is becoming increasingly popular worldwide because of its many advantages. These advantages include shorter hospital stays, faster recoveries, and lower overall treatment costs. Further, the increasing prevalence of diseases like cardiovascular disease, arthritis, and cancer is increasing the demand for a minimally invasive medical procedure, as the treatment of these diseases is complex and requires extensive precision, thus further increasing the demand for catheters and medical tubing in the healthcare industry. Hospitals and medical facilities are experiencing a significant increase in demand for medical tubing because of its high potential and low cost.
Significant Investments and Time Required For Product Development
Medical tubing production is a time-consuming and costly process. Reduced funding for medical product development technology directly results from lengthy regulatory approval processes, which lengthen the entire development process. Because of the high cost and time commitment associated with fixing technical and biocompatibility issues, the market is constantly undergoing product innovation to eliminate these problems. For instance, extensive R&D and technical expertise are required when choosing the best polymer for a given medical application and analyzing the scope of use for each polymer in medical tubing. One example is the potential future increase in time needed for FDA approval of medical devices due to the complexity and expense of FDA regulations. Manufacturers face challenges in commercialization and marketing due to regulatory approval processes that vary from region to region.
High Initial Investments in Healthcare Sector
Increases in foreign direct investment (FDI), favorable reimbursement policies, and public and private spending have contributed to the healthcare industry's rapid expansion over the past few years. Numerous opportunities for medical tubing exist in the healthcare and medical device industries as the healthcare market in developing countries undergoes significant changes due to shifting customer demands, expanding healthcare knowledge, and aging populations. Market expansion in developing nations is driven by improving economic conditions, increased public spending on healthcare infrastructure, and rising consumer purchasing power. Thus, rising investments in healthcare infrastructure present a sizable opportunity for the medical tubing market.
The global medical tubing market is segmented by component, deployment, organization size, and application.
Based on material, the global medical tubing market is bifurcated into silicone, polyvinyl chloride, polyolefins, polycarbonates, fluoropolymers, and others.
The polyvinyl chloride segment is the highest contributor to the market and is expected to grow during the forecast period. As a versatile thermoplastic, polyvinyl chloride (PVC) is frequently used to produce intravenous and other medical tubing. It's also used to make blood bags and other containers that can't be broken. PVC bags are widely used in the medical device industry due to their accommodating properties (they are quiet and don't leak odors). PVC-based medical devices are in higher demand due to the rising popularity of one-time-use, pre-sterilized medical tools. Both irradiation and ethylene oxide sterilization can be used to safely and effectively sanitize PVC. Improved chemical resistance and many sterilization options reveal its impressive stability across a broad temperature range.
Based on application, the global medical tubing market is bifurcated into drug delivery systems, catheters, biopharmaceutical laboratory equipment, disposable tubing, and others.
The catheter segment is the highest contributor to the market and is expected to grow during the forecast period. Catheters from medical tubes are widely used in many medical procedures, such as angiography, electrophysiology (EP) ablation, and urinary catheterization. Leading market players' efforts to quicken the pace of innovation are a significant force propelling the sector forward. For medical or surgical purposes, they are injected into patients. Increasing numbers of people worldwide are hospitalized for chronic conditions, which has boosted the demand for catheters. Catheters are in higher need in healthcare facilities and OT due to the rising incidence of cardiovascular, nephrological, neurological, gastrointestinal, and other diseases among the elderly. As a result, the demand for catheters is anticipated to expand shortly.
The global medical tubing market is bifurcated into four regions, namely North America, Europe, Asia-Pacific, and LAMEA.
North America Dominates the Global Market
Regional Growth Insights Request Sample Pages
North America is the most significant shareholder in the global medical tubing market and is expected to grow during the forecast period. Leading market players are conducting extensive research to develop novel products. They are engaging in several mergers and acquisitions because the region is so attractive to investors. Due to factors such as rising healthcare expenditure, substantial healthcare facilities, and technological advancements, a large patient pool, and increased investment from market players, the United States currently holds a dominant position in the regional market. Vinyl compounds, thermoplastic urethanes, polyolefins, and polyamides are just a few of the polymer options available in the country for medical tubing. As a result of government spending increases and collaboration with health insurance providers, the healthcare sector in this area has improved significantly.
Europe is expected to grow during the forecast period. The rising geriatric population, chronic disease rates, new medical technologies, and other factors are all contributing to the improvement of healthcare delivery. The markets for medical tubing in the United Kingdom, Russia, France, and Germany are significant. As a result of strict regulations imposed by the European Commission and Member States Health Authorities for the production of medical tubing, however, the market is slowing down. Also, Europe is the largest provider of healthcare exports to the United States, making up some 38% of the total market.
Due to factors including an aging population, a growing healthcare industry, a large patient pool, increasing government support, and a growing awareness of the importance of health and wellness, Asia-Pacific is quickly becoming the region with the largest share of the global medical tubing market. As a result of the increasing number of patients, the leading companies in the area are working hard to develop low-cost medical tubing solutions, fueling the market's expansion. Natvar's silicone extrusion tubing, feeding tubes, catheters, and peristaltic pump applications are all made in this state-of-the-art facility. As everyone knows, Natvar is the company's go-to source for medical tubing solutions worldwide.
Several factors contribute to the increased need for medical care in Central and South America. These include an aging population due to increased life expectancy, fewer births, and the prevalence of chronic diseases. Additionally, the number of public-private partnerships is growing in this industry. Thus, the growing healthcare industry and the enhancements to the healthcare infrastructure are expected to propel regional market expansion. A growing elderly population and a greater interest in minimally invasive surgical procedures also contribute to this growth.
The global medical tubing market’s major key players are Zeus Industrial Products, Lubrizol Corporation, Saint-Gobain Performance Plastics, Putnam Plastics, Tekni-Plex, Teleflex, Optinova, Nordson Corporation, RAUMEDIC AG, and W. L. Gore & Associates.
|Market Size||USD 19.52 in Billion By 2031|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends|
|Segments Covered||by Material (Silicone, Polyvinyl Chloride, Polyolefins), Application (Catheters, Drug Delivery Systems, Disposable Tubing)|
|Geographies Covered||North America, Europe, Asia-Pacific, LAME and Rest of the World|
|Key Companies Profiled/Vendors||Zeus Industrial Products (U.S.), Lubrizol Corporation (Vesta) (US), Saint-Gobain Performance Plastics (France), Putnam Plastics (U.S.), Tekni-Plex (U.S.), Teleflex (U.S.), Optinova (U.S.), Nordson Corporation (U.S.), RAUMEDIC AG (Germany), and WLGore & Associates (U.S.)|
|Key Market Opportunities||Rising Demand For Medical Tubing In Healthcare It Industry|